IQ EQ FUND MANAGEMENT IRELAND Ltd Has $1.45 Million Stock Holdings in Intuitive Surgical, Inc. $ISRG

IQ EQ FUND MANAGEMENT IRELAND Ltd lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 52.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,251 shares of the medical equipment provider’s stock after buying an additional 1,115 shares during the quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd’s holdings in Intuitive Surgical were worth $1,454,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also modified their holdings of ISRG. Tobam boosted its holdings in Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 40 shares during the period. Kilter Group LLC acquired a new position in shares of Intuitive Surgical during the 2nd quarter worth about $27,000. Princeton Global Asset Management LLC bought a new stake in Intuitive Surgical during the 2nd quarter valued at approximately $30,000. Greykasell Wealth Strategies Inc. acquired a new stake in Intuitive Surgical in the 3rd quarter valued at approximately $27,000. Finally, Riggs Asset Managment Co. Inc. grew its holdings in Intuitive Surgical by 84.2% in the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock valued at $38,000 after buying an additional 32 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Analysts Set New Price Targets

ISRG has been the subject of several research reports. Zacks Research cut Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, January 21st. TD Cowen raised shares of Intuitive Surgical to a “strong-buy” rating in a report on Tuesday, January 27th. BTIG Research restated a “buy” rating and set a $616.00 price objective on shares of Intuitive Surgical in a report on Friday, January 23rd. The Goldman Sachs Group reaffirmed a “buy” rating and set a $714.00 price objective on shares of Intuitive Surgical in a research report on Friday, January 9th. Finally, Mizuho set a $575.00 target price on Intuitive Surgical in a research report on Wednesday, October 22nd. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $617.23.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $488.15 on Friday. The firm has a market cap of $173.36 billion, a P/E ratio of 61.87, a price-to-earnings-growth ratio of 3.70 and a beta of 1.65. The firm’s 50-day simple moving average is $549.63 and its 200-day simple moving average is $510.54. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $609.08.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The firm had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same quarter last year, the company earned $2.21 earnings per share. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Henry L. Charlton sold 13,731 shares of the business’s stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total value of $7,963,980.00. Following the sale, the executive vice president owned 3,056 shares in the company, valued at approximately $1,772,480. The trade was a 81.80% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Brian Edward Miller sold 3,500 shares of the company’s stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the completion of the sale, the executive vice president directly owned 5,758 shares in the company, valued at approximately $3,310,850. The trade was a 37.81% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 73,616 shares of company stock worth $40,929,575 over the last three months. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.